GSFA Provisions for Natamycin (Pimaricin)

Number Food Category Max dosage level* Application
comments
01.6.1 Unripened cheese 40 mg/kg Surface treatment. Equivalent to 2 mg/dm2 surface application to a maximum depth of 5 mm.
01.6.2 Ripened cheese 40 mg/kg Surface treatment. Equivalent to 2 mg/dm2 surface application to a maximum depth of 5 mm.
01.6.4 Processed cheese 40 mg/kg Surface treatment. Equivalent to 2 mg/dm2 surface application to a maximum depth of 5 mm.
01.6.5 Cheese analogues 40 mg/kg Surface treatment. Equivalent to 2 mg/dm2 surface application to a maximum depth of 5 mm.
01.6.6 Whey protein cheese 40 mg/kg Surface treatment. Equivalent to 2 mg/dm2 surface application to a maximum depth of 5 mm.
08.2.1.2 Cured (including salted) and dried non-heat treated processed meat, poultry, and game products in whole pieces or cuts 6 mg/kg
08.3.1.1 Cured (including salted) and dried non-heat treated processed comminuted meat, poultry, and game products 20 mg/kg Surface treatment. Equivalent to 1 mg/dm2 surface application to a maximum depth of 5 mm.

*Pure Natamycin

(c) FAO and WHO 2009

Difference between Nisin A and Nisin Z

Nisin A and Nisin Z are of vegetal origin, two natural variants of the Nisin that are produced by Lactococcus lactis are known. They have a similar structure but differ in a single amino acid residue at position 27; histidine in Nisin A and asparagine in Nisin Z. The Nisin variants were purified to apparent homogeneity, and their biological activities were compared. Identical MICs of Nisin A and Nisin Z were found with all tested indicator strains of six different species of gram-positive bacteria. However, at concentrations above the MICs, with Nisin Z the inhibition zones obtained in agar diffusion assays were invariably larger than those obtained with Nisin A. This was observed with all tested indicator strains. These results suggest that Nisin Z has better diffusion properties than Nisin A in agar. The distribution of the Nisin variants in various lactococcal strains was determined by amplification of the Nisin structural gene by polymerase chain reaction followed by direct sequencing of the amplification product. In this way, it was established that the nisZ gene for Nisin Z production is widely distributed, having been found in 14 of the 26 L. lactis strains analyzed.

The solubility of Nisin A is highest at low pH values and gradually decreases by almost 2 orders of magnitude when the pH of the solution exceeds a value of 7. At low pH, Nisin Z exhibits a decreased solubility relative to that of Nisin A; at neutral and higher pH values, the solubilities of both variants are comparable. Two mutants of Nisin Z, which contain lysyl residues at positions 27 and 31, respectively, instead of Asn-27 and His-31, were produced with the aim of reaching higher solubility at neutral pH. Both mutants were purified to homogeneity, and their structures were confirmed by one-and two-dimensional 1H nuclear magnetic resonance.

Their antimicrobial activities were found to be similar to that of Nisin Z, whereas their solubilities at pH 7 increased by factors of 4 and 7, respectively. The chemical stability of Nisin A was studied in the pH range of 2 to 8 and at a 20, 37, and 75 degrees C. Optimal stability was observed at pH 3.0. Nisin Z showed a behavior similar to that of Nisin A. A mutant containing dehydrobutyrine at position 5 instead of dehydroalanine had lower activity but were significantly more resistant to acid-catalyzed chemical degradation than wild-type Nisin Z.

Sources: HS Rollema, OP Kuipers, P Both, WM de Vos and RJ Siezen Department of Biophysical Chemistry, Netherlands Institute for Dairy Research (NIZO), Ede.

Nisin (E234) food application in EU

Ingredient Applications Max dosage level*
Nisin (E234) Semolina and tapioca puddings and similar products 120 mg/kg
Ripened cheese and processed cheese 500 mg/kg
Clotted cream 400 mg/kg
Mascarpone 400 mg/kg
Pasteurised liquid egg (white, yolk or whole egg) 250 mg/kg

*The dosage shown refers to 2,5% nisin preparation in NaCl.

Siveele visit Anuga 2013 in Cologne

Siveele team goes to visit Anuga 2013 in Cologne.

Visit Siveele at booth 91B76 in FIE 2013!

Siveele will attend FIE 2013 in Frankfurt. Visit us at booth 91B76.

New website online!

Our new website is online! The website is still “work in progress”, but our clients can already have a sneak peek of our new portal.

Nataseen® INCI name assigned

Due to its high effectiveness against yeasts and moulds, Nataseen® is also suitable for cosmetics applications.
In 2013, Siveele B.V. applied INCI (International Nomenclature of Cosmetic Ingredients) name application (No. 4-03-2013-0493) for Nataseen® (Natamycin), and it was assigned as NATAMYCIN by the International Nomenclature Committee on 11 July, 2013.

Siveele featured on FoodNavigator.com

The prominent online portal for news on food & beverage development has interviewed Siveele’s Director of Marketing and Sales to have an insight on the cooperation with Chinese enzyme manufacturer Pangbo.

Read the full article

Siveele featured in the (Dutch) press!

Siveele staff have been asked their view on working in the Netherlands, and concerning their role – inter alia – as gateway for Asian products.

Download and read the full article  (© De Volkskrant, 2012 – In Dutch language)

Chitosan study highlights anti-aging and wound-healing properties

The antimicrobial activity of chitosan microparticles would benefit both wound-healing and anti-aging skin care – according to researchers at Fairleigh Dickinson University.

Chitosan, a natural antimicrobial obtained from shrimp shells, is one of the natural products offered by Siveele.

Read the full article